A novel nonsense mutation in androgen receptor confers resistance to CYP17 inhibitor treatment in prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A novel nonsense mutation in androgen receptor confers resistance to CYP17 inhibitor treatment in prostate cancer

Published:2016-12-27 Issue:4 Volume:8 Page:6796-6808
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Han Dong¹,Gao Shuai¹²,Valencia Kevin¹,Owiredu Jude¹,Han Wanting¹,de Waal Eric³,Macoska Jill A.¹,Cai Changmeng¹²

Affiliation:

1. Center for Personalized Cancer Therapy, University of Massachusetts Boston, Boston, Massachusetts 02125, USA

2. Hematology-Oncology Division and Cancer Center, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215, USA

3. Biology Department, University of Suffolk, Boston, Massachusetts 02108, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overcoming resistance in prostate cancer with targeted and small molecule-based therapies;Therapy Resistance in Prostate Cancer;2024

2. Optimized EGFR Blockade Strategies in EGFR Addicted Gastroesophageal Adenocarcinomas;Clinical Cancer Research;2021-02-04

3. Roles of Reactive Oxygen Species in Biological Behaviors of Prostate Cancer;BioMed Research International;2020-09-29

4. Castration-Resistant Prostate Cancer Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents: Opportunities and Challenges;Cancers;2018-09-21

5. Androgen receptor: what we know and what we expect in castration-resistant prostate cancer;International Urology and Nephrology;2018-08-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP